255 related articles for article (PubMed ID: 11099168)
1. Influence of the angiotensin II AT1 receptor antagonist irbesartan on ischemia/reperfusion injury in the dog heart.
Preckel B; Schlack W; Gonzàlez M; Obal D; Barthel H; Thämer V
Basic Res Cardiol; 2000 Oct; 95(5):404-12. PubMed ID: 11099168
[TBL] [Abstract][Full Text] [Related]
2. Effect of acidotic blood reperfusion on reperfusion injury after coronary artery occlusion in the dog heart.
Preckel B; Schlack W; Obal D; Barthel H; Ebel D; Grunert S; Thämer V
J Cardiovasc Pharmacol; 1998 Feb; 31(2):179-86. PubMed ID: 9475258
[TBL] [Abstract][Full Text] [Related]
3. Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT1-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs.
Shimizu M; Wang QD; Sjöquist PO; Rydén L
J Cardiovasc Pharmacol; 1999 Oct; 34(4):512-7. PubMed ID: 10511125
[TBL] [Abstract][Full Text] [Related]
4. Effects of local inhibition of the cardiac renin-angiotensin system with CV-11974 in a canine ischaemia-reperfusion model.
So T; Nakashima Y; Imamura M; Arakawa K
Clin Exp Pharmacol Physiol; 1998; 25(7-8):503-9. PubMed ID: 9673420
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic angiotensin receptor blockade on myocardial vascular blood volume and perfusion in a pig model of coronary microembolization.
Schmermund A; Lerman LO; Rumberger JA; Lund PE; Pfeifer EA; Sheedy PF; Ritman EL
Am J Hypertens; 2000 Jul; 13(7):827-37. PubMed ID: 10933576
[TBL] [Abstract][Full Text] [Related]
6. AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.
Jugdutt BI; Menon V
Mol Cell Biochem; 2004 May; 260(1-2):111-8. PubMed ID: 15228092
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 1 receptor blockade with candesartan protects the porcine myocardium from reperfusion-induced injury.
Shimizu M; Wang QD; Sjöquist PO; Rydén L
J Cardiovasc Pharmacol; 1998 Aug; 32(2):231-8. PubMed ID: 9700985
[TBL] [Abstract][Full Text] [Related]
8. Influence of angiotensin II type 1-receptor antagonist CV11974 on infarct size and adjacent regional function after ischemia-reperfusion in dogs.
Miyoshi H; Takayama Y; Kitashiro S; Izuoka T; Saito D; Imuro Y; Mimura J; Yamamoto S; Tokioka M; Iwasaka T
Jpn J Pharmacol; 2002 Jun; 89(2):120-5. PubMed ID: 12120753
[TBL] [Abstract][Full Text] [Related]
9. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
Culman J; von Heyer C; Piepenburg B; Rascher W; Unger T
Eur J Pharmacol; 1999 Feb; 367(2-3):255-65. PubMed ID: 10079000
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor antagonist EXP 3174 reduces infarct size comparable with enalaprilat and augments preconditioning in the pig heart.
Schwarz ER; Montino H; Fleischhauer J; Klues HG; vom Dahl J; Hanrath P
Cardiovasc Drugs Ther; 1997 Nov; 11(5):687-95. PubMed ID: 9493708
[TBL] [Abstract][Full Text] [Related]
11. Intracoronary SIN-1C during reperfusion reduces infarct size in dog.
Schlack W; Uebing A; Schäfer M; Bier F; Grunert S; Ebel D; Piper HM; Thämer V
J Cardiovasc Pharmacol; 1995 Mar; 25(3):424-31. PubMed ID: 7769808
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral pretreatment with metoprolol on left ventricular wall motion, infarct size, hemodynamics, and regional myocardial blood flow in anesthetized dogs during thrombotic coronary artery occlusion and reperfusion.
Zmudka K; Dubiel J; Vanhaecke J; Flameng W; De Geest H
Cardiovasc Drugs Ther; 1994 Jun; 8(3):479-87. PubMed ID: 7947365
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels.
Kersten JR; Schmeling TJ; Hettrick DA; Pagel PS; Gross GJ; Warltier DC
Anesthesiology; 1996 Oct; 85(4):794-807; discussion 27A. PubMed ID: 8873550
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin II AT1-receptor blockade on coronary dynamics, function, and structure in postischemic heart failure in rats.
Gervais M; Fornes P; Richer C; Nisato D; Giudicelli JF
J Cardiovasc Pharmacol; 2000 Sep; 36(3):329-37. PubMed ID: 10975590
[TBL] [Abstract][Full Text] [Related]
16. Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts.
Ford WR; Clanachan AS; Jugdutt BI
Circulation; 1996 Dec; 94(12):3087-9. PubMed ID: 8989113
[TBL] [Abstract][Full Text] [Related]
17. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
Wang QD; Sjöquist PO
Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
Jugdutt BI; Menon V
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):217-26. PubMed ID: 14506547
[TBL] [Abstract][Full Text] [Related]
20. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
